HSA — authorised 1 April 1968
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
HSA authorised Desferal on 1 April 1968
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 1 April 1968.
NOVARTIS holds the Singaporean marketing authorisation.